Preclinical studies of WVE-210201, an investigational stereopure antisense oligonucleotide in development for the treatment of patients with duchenne muscular dystrophy (DMD)

Preclinical studies of WVE-210201, an investigational stereopure antisense oligonucleotide in development for the treatment of patients with duchenne muscular dystrophy (DMD)

Бібліографічні деталі
Автори: Panzara, M, Zhang, J, Rinaldi, C, McClorey, G, Bowman, K, Butler, D, Dodart, J, Frank-Kamenetsky, M, Iwamoto, N, Kothari, N, Lu, G, Mathieu, S, M, M, Melkonian, M, Menon, S, Standley, S, Yang, H, Zhong, Z, Wood, M, Vargeese, C
Формат: Conference item
Опубліковано: Elsevier 2017

Схожі ресурси